China makes headway on trade secret reform

As China readies to deliberate a draft of its first IP overhaul in over a decade, the government has recently passed two laws and one regulation that could help shield biopharma companies from IP loss.

Mark Cohen, head of the Asia IP project at Berkeley Law and former senior counsel at the U.S. Patent and Trademark Office (USPTO), said that China is focusing on legislation sensitive to trade issues...